33
Participants
Start Date
April 4, 2017
Primary Completion Date
February 12, 2018
Study Completion Date
February 12, 2018
iHIVARNA-01
Therapeutic vaccination, followed by treatment interruption
TriMix
Therapeutic vaccination, followed by treatment interruption
Placebo
Therapeutic vaccination, followed by treatment interruption
Institute for Tropical Medicine, Antwerp
UZ Brussel, Brussels
Erasmus MC, Rotterdam
Hospital Universitari Germans Trias i Pujol, Badalona
Hospital Clinic, Barcelona
Collaborators (3)
Institut d'Investigacions Biomèdiques August Pi i Sunyer
OTHER
IrsiCaixa
OTHER
Institute of Tropical Medicine, Belgium
OTHER
Vrije Universiteit Brussel
OTHER
Synapse bv
INDUSTRY
Asphalion
UNKNOWN
eTheRNA immunotherapies
INDUSTRY
CR2O
UNKNOWN
Hospital Clinic of Barcelona
OTHER
Germans Trias i Pujol Hospital
OTHER
Universitair Ziekenhuis Brussel
OTHER
Rob Gruters
OTHER